Antitumor Effect of FGFR Inhibitors on a Novel Cholangiocarcinoma Patient Derived Xenograft Mouse Model Endogenously Expressing an FGFR2-CCDC6 Fusion Protein

Cancer Letters - Ireland
doi 10.1016/j.canlet.2016.05.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

The Specific Serotonin Reuptake Inhibitors Sertraline and Fluoxetine Promote Tumor Growth in a Mouse Xenograft Model of Cholangiocarcinoma

Matters
2017English

Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

Cancer Research
Cancer ResearchOncology
2014English

HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma

Hepatology
MedicineHepatology
2018English

Patient-Derived Cancer Xenograft Xebrafish Model (PDXZ) and Personalized Medicine

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-Positive Intrahepatic Cholangiocarcinoma

British Journal of Cancer
Cancer ResearchOncology
2018English

Antitumor Activity of T Cells Reactive Against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model

Cancer Research
Cancer ResearchOncology
2009English

Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2018English

Development of a Patient-Derived Xenograft Model of Glioblastoma via Intravitreal Injection in Mice

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy